[Federal Register Volume 72, Number 201 (Thursday, October 18, 2007)]
[Notices]
[Pages 59099-59100]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-20550]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Science Board to the Food and Drug Administration; Amendment of 
Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the Science Board to the Food and Drug 
Administration (Science Board). This meeting was originally announced 
in the Federal Register of October 2, 2007 (72 FR 56078). The amendment 
is being made to reflect a change in the Date and Time and Procedure 
portions of the document. There are no other changes.

FOR FURTHER INFORMATION CONTACT: Carlos Pe[ntilde]a, Office of the 
Commissioner, Food and Drug Administration (HF-33), 5600 Fishers Lane, 
Rockville, MD, 20857, 301-827-6687, carlos.Pe[ntilde][email protected], or 
FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 
in the Washington, DC area), code 3014512603.

SUPPLEMENTARY INFORMATION: In the Federal Register of October 2, 2007, 
FDA announced that a meeting of the Science Board would be held on 
October 30, 2007. On page 56078, beginning in the second column, the 
Date and Time and Procedure portions of the document are amended to 
read as follows:
    Date and Time: The meeting will be held on December 3, 2007, from 8 
a.m. to 5:30 p.m.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person on or before 
November 26, 2007. Oral presentations from the public will be scheduled 
between approximately 4 p.m. and 5 p.m. Those desiring to make formal 
oral presentations should notify the contact person and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their presentation 
on

[[Page 59100]]

or before November 16, 2007. Time allotted for each presentation may be 
limited. If the number of registrants requesting to speak is greater 
than can be reasonably accommodated during the scheduled open public 
hearing session, FDA may conduct a lottery to determine the speakers 
for the scheduled open public hearing session. The contact person will 
notify interested persons regarding their request to speak by November 
19, 2007.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

    Dated: October 12, 2007.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E7-20550 Filed 10-17-07; 8:45 am]
BILLING CODE 4160-01-S